Hamburg TranscathEteR Mitral Valve REplacement RegiStry

Recruiting now

Conditions studied: Mitral Valve Disease

In brief

The Hamburg TranscathEteR Mitral Valve REplacement RegiStry (HERMES) is a prospective clinical cohort registry aiming to gather follow-up information on short- and long-term outcome of patients with mitral valve disease that undergo transcatheter mitral valve replacement (TMVR) screening. In particular, long-term durability and function of implanted bioprosteses is of utmost interest for both patients and clinicians. Moreover, this study aimes to investigate and compare the different treatment strategies patients undergo after successful or unsuccessful screening for TMVR.

Key facts

Study ID

NCT04914468

Run by

Universitätsklinikum Hamburg-Eppendorf

People needed

300

Starts

2021-03-08

Expected to finish

2030-12-31

Last updated by the study team

2021-06-04

Who can join

Age: 18 and older, up to 110. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Ability to provide written informed consent in accordance with Good Epidemiological Practice and local legislation.
• Individuals over the age of 18 years.
• Patients with clinically relevant mitral valve disease, who undergo screening for TMVR.

You may not qualify if…

• Insufficient knowledge of the German language, to understand study documents and interview without translation
• Physical or psychological incapability to cooperate in the investigation

Where it is running

• University Heart and Vascular Center Hamburg — Hamburg, Germany (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.